LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
11.54
-0.03 (-0.26%)
At close: Jan 12, 2026, 4:00 PM EST
11.54
0.00 (0.00%)
After-hours: Jan 12, 2026, 4:10 PM EST
LENSAR Market Cap
LENSAR has a market cap or net worth of $137.84 million as of January 12, 2026. Its market cap has increased by 37.20% in one year.
Market Cap
137.84M
Enterprise Value
123.85M
1-Year Change
37.20%
Ranking
Category
Stock Price
$11.54
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $137.84M, an increase of 76.70%. That is a compound annual growth rate of 11.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 138.20M | -0.52% |
| Dec 31, 2025 | 138.92M | 33.78% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |